Matthew B. Zook Joins the Dermatology Team at Fox Chase Cancer Center
Philadelphia (July 7, 2009) – Matthew B. Zook, MD, PhD, has joined Fox Chase’s dermatology team as director of the Melanoma Family Risk Assessment Program (MELFRAP). He treats patients with pigmented lesions, melanoma and other skin cancers.
The MELFRAP is the newest component of Fox Chase’s comprehensive program for melanoma. It provides risk assessment, prevention and early detection of melanoma and complements the Center’s state-of-the-art services of staging and treatment. Zook will oversee a staff that is dedicated to helping people prevent melanoma and other forms of skin cancer by understanding their personal and family risk and learning ways to reduce it.
“I chose to come to Fox Chase because the Center has really established itself as an institution dedicated to clinical excellence,” said Zook. “Above all else I found that Fox Chase fosters a welcoming, patient oriented environment.”
Zook earned his medical degree from Jefferson Medical College, Thomas Jefferson University in Philadelphia, Pa. Prior to that, Zook received a PhD in microbiology and molecular virology at the College of Graduate Studies, Thomas Jefferson University.
Following his medical training, Zook completed an internship in the Department of Medicine at Albert Einstein Medical Center in Philadelphia. He completed a fellowship in dermatology and cutaneous biology at Thomas Jefferson University.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy6 Moore at 215-728-2700.